Home

Download

Statistics

Landscape

Help

Contact

	Dataset summary
	Drug summary
	Umap of single cell types and conditions (resistant and sensitive)
	Comparison of cell composition between the resistant and sensitive groups
	Comparison of intra-tumor heterogeneity (ITH) and epithelial-mesenchymal transition (EMT) scores of malignant cells between the resistant and sensitive groups (This dataset does not contain this module)
	Difference of cell-cell interactions between the resistant and sensitive groups
	Differentially expressed genes (DEGs) between the resistant and sensitive groups for each cell type
	Mechanism analysis of drug resistance-related DEGs for each cell type in the pre-treatment samples
	Mechanism analysis of drug resistance-related DEGs for each cell type in the post-treatment samples
	Mechanism analysis of drug resistance-related DEGs for each cell type in one patient or cell lines (This dataset does not contain this module)
	MicroRNAs (miRNAs) regulating drug resistance-related DEGs for Malignant cells
	Motifs and transcription factors (TFs) regulating drug resistance-related DEGs for each cell type
•	Differentially expressed genes act as transcription factors

Dataset: GSE169246_PacBlood

Dataset summary for GSE169246_PacBlood

Datast information	Dataset	GSE169246_PacBlood
	PMID	34653365
	Raw data ID/link	NA
	Organism	Homo sapiens
	Source	patients
	Tissue	Peripheral blood mononuclear cells
	Cancer type level1	Breast cancer
	Cancer type level2	Advanced triple-negative breast cancer (TNBC)
	Regimen	paclitaxel
	Drug type	Chemotherapy
	Sample size	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)
	Cell number	120823
	Extract protocol	10x genomics
	Data processing	CellRanger 3.0.0
	Public date	Public on Sep 15, 2021
	Description	This dataset has 9 patients with both pre -and post-treatment samples.

Top

Drug summary for GSE169246_PacBlood

Drug name	DrugBank ID	Drug type	Targets name	Targets uniprot ID
"Paclitaxel"	DB01229	small molecule	TUBB1; BCL2; MAP4; MAP2; MAPT; NR1I2	Q9H4B7; P10415; P27816; P11137; P10636; O75469

Top

Umap of single cell types and conditions (resistant and sensitive)

Umap of cell types and conditions (resistant and sensitive). If this dataset has both pre-treatment and post-treatment samples, the cell types were annotated together. If this dataset is a cell line dataset, the UMAP of cell clusters and the cell ratio of drug-resistant and sensitive groups within each cluster will also be shown. (If the image exists, the user can click on it to enlarge it in a new window.)

Umap of cell types

Umap of conditions

Top

Comparison of cell composition between the resistant and sensitive groups

In the pre-treatment samples, the cell composition of the resistant and sensitive groups were compared.
* represents significant difference. (If the image exists, the user can click on it to enlarge it in a new window.)

In the post-treatment samples, the cell composition of the resistant and sensitive groups were compared.
* represents significant difference. (If the image exists, the user can click on it to enlarge it in a new window.)

Top

Comparison of ITH and EMT scores of malignant cells between the resistant and sensitive groups

Comparison of ITH (intra-tumoral heterogeneity) and EMT (epithelial-mesenchymal transition) scores of malignant cells between the resistant and sensitive groups. ITH represents intratumoral heterogeneity, EMT represents epithelial mesenchymal transition, pre represents pre-treatment, post represents post-treatment, post2 represents longer post-treatment. (If the image exists, the user can click on it to enlarge it in a new window.)

Top

Difference of cell-cell interactions between the resistant and sensitive groups

In the pre-treatment samples, the difference in cell-cell interactions between the resistant and sensitive groups was compared. The numbers indicate the count of cell-cell interactions that were either higher or lower in the resistant group compared to the sensitive group. The dot plots of significant ligand-receptor pairs in the resistant group and sensitive group are subsequently displayed. (If the image exists, the user can click on it to enlarge it in a new window. Complete files can be downloaded from the download section.)

resistant vs. sensitive

Dot plot of significant ligand-receptor pairs in the resistant group	Dot plot of significant ligand-receptor pairs in the sensitive group

In the post-treatment samples, the difference in cell-cell interactions between the resistant and sensitive groups was compared. The numbers indicate the count of cell-cell interactions that were either higher or lower in the resistant group compared to the sensitive group. The dot plots of significant ligand-receptor pairs in the resistant group and sensitive group are subsequently displayed. (If the image exists, the user can click on it to enlarge it in a new window. Complete files can be downloaded from the download section.)

resistant vs. sensitive

Dot plot of significant ligand-receptor pairs in the resistant group	Dot plot of significant ligand-receptor pairs in the sensitive group

This dataset only has one patient or is a cell line dataset, the resistant sample is the post-treatment sample and the sensitive sample is the pre-treatment sample. The difference in cell-cell interactions between the resistant and sensitive groups was compared. The numbers indicate the count of cell-cell interactions that were either higher or lower in the resistant group compared to the sensitive group. The dot plots of significant ligand-receptor pairs in the resistant group and sensitive group are subsequently displayed. (If the image exists, the user can click on it to enlarge it in a new window. Complete files can be downloaded from the download section.)

Top

Differentially expressed genes (DEGs) between the resistant and sensitive groups for each cell type

In the pre-treatment samples, the differentially expressed genes (|avg_log2FC|>0.25 & p_val_adj<0.05) between the resistant and sensitive groups for each cell type.

Gene symbol	Gene id	avg_log2FC	p_val	p_val_adj	pct.1	pct.2	Cell type	Timepoint
LRRFIP1	ENSG00000124831	0.34201	0.00e+00	0.00e+00	0.688	0.526	NK cells	pre
TRAF3IP3	ENSG00000009790	0.341999	0.00e+00	0.00e+00	0.759	0.62	NK cells	pre
STAT4	ENSG00000138378	0.340497	0.00e+00	0.00e+00	0.486	0.314	NK cells	pre
RBMS1	ENSG00000153250	0.340361	0.00e+00	0.00e+00	0.481	0.279	NK cells	pre
SPTAN1	ENSG00000197694	0.340282	0.00e+00	0.00e+00	0.454	0.275	NK cells	pre
CBLB	ENSG00000114423	0.339789	0.00e+00	0.00e+00	0.414	0.25	NK cells	pre
RNF125	ENSG00000101695	0.339739	0.00e+00	0.00e+00	0.461	0.292	NK cells	pre
WAS	ENSG00000015285	0.339247	0.00e+00	0.00e+00	0.541	0.34	NK cells	pre
ITCH	ENSG00000078747	0.339224	0.00e+00	0.00e+00	0.364	0.17	NK cells	pre
ARF6	ENSG00000165527	0.339034	0.00e+00	0.00e+00	0.562	0.372	NK cells	pre
CAST	ENSG00000153113	0.337367	0.00e+00	0.00e+00	0.691	0.557	NK cells	pre
VPS13C	ENSG00000129003	0.336478	0.00e+00	0.00e+00	0.464	0.292	NK cells	pre
ARGLU1	ENSG00000134884	0.336351	0.00e+00	0.00e+00	0.592	0.425	NK cells	pre
CDC42EP3	ENSG00000163171	0.335265	0.00e+00	0.00e+00	0.477	0.296	NK cells	pre
TAF15	ENSG00000276833	0.334804	0.00e+00	0.00e+00	0.449	0.253	NK cells	pre
ATP2B4	ENSG00000058668	0.332948	0.00e+00	0.00e+00	0.514	0.34	NK cells	pre
IL2RB	ENSG00000100385	0.332744	0.00e+00	0.00e+00	0.574	0.435	NK cells	pre
CST3	ENSG00000101439	0.332157	0.00e+00	0.00e+00	0.284	0.106	NK cells	pre
ARHGAP30	ENSG00000186517	0.330725	0.00e+00	0.00e+00	0.567	0.384	NK cells	pre
ATF7IP	ENSG00000171681	0.330479	0.00e+00	0.00e+00	0.401	0.229	NK cells	pre
HLA-E	ENSG00000206493	0.329794	0.00e+00	0.00e+00	0.998	0.991	NK cells	pre
ITK	ENSG00000113263	0.328095	0.00e+00	0.00e+00	0.383	0.227	NK cells	pre
DDX6	ENSG00000110367	0.327868	0.00e+00	0.00e+00	0.492	0.318	NK cells	pre
ADAR	ENSG00000160710	0.327699	0.00e+00	0.00e+00	0.52	0.345	NK cells	pre
CCNL1	ENSG00000163660	0.327367	0.00e+00	0.00e+00	0.429	0.263	NK cells	pre
ETS1	ENSG00000134954	0.327327	0.00e+00	0.00e+00	0.601	0.476	NK cells	pre
MYO1F	ENSG00000142347	0.327076	0.00e+00	0.00e+00	0.616	0.455	NK cells	pre
STAT3	ENSG00000168610	0.326945	0.00e+00	0.00e+00	0.467	0.277	NK cells	pre
CYFIP2	ENSG00000055163	0.326071	0.00e+00	0.00e+00	0.576	0.414	NK cells	pre
WIPF1	ENSG00000115935	0.32584	0.00e+00	0.00e+00	0.638	0.484	NK cells	pre
VCP	ENSG00000165280	0.324459	0.00e+00	0.00e+00	0.517	0.34	NK cells	pre
CEMIP2	ENSG00000135048	0.323581	0.00e+00	0.00e+00	0.31	0.134	NK cells	pre
B4GALT1	ENSG00000086062	0.323145	0.00e+00	0.00e+00	0.323	0.139	NK cells	pre
FGFBP2	ENSG00000137441	0.322428	0.00e+00	0.00e+00	0.748	0.628	NK cells	pre
ADGRE5	ENSG00000123146	0.321067	0.00e+00	0.00e+00	0.587	0.428	NK cells	pre
EMB	ENSG00000170571	0.321029	0.00e+00	0.00e+00	0.465	0.299	NK cells	pre
KLRG1	ENSG00000139187	0.320244	2.37e-23	4.67e-19	0.521	0.493	NK cells	pre
INPP5D	ENSG00000281614	0.320043	0.00e+00	0.00e+00	0.453	0.275	NK cells	pre
SRSF4	ENSG00000116350	0.317912	0.00e+00	0.00e+00	0.438	0.243	NK cells	pre
CDK17	ENSG00000059758	0.317628	0.00e+00	0.00e+00	0.325	0.143	NK cells	pre
SH3BP5	ENSG00000131370	0.31538	0.00e+00	0.00e+00	0.448	0.269	NK cells	pre
EVI2B	ENSG00000185862	0.315175	0.00e+00	0.00e+00	0.386	0.206	NK cells	pre
HLA-C	ENSG00000206435	0.314817	0.00e+00	0.00e+00	1	0.999	NK cells	pre
SMAP2	ENSG00000084070	0.314257	0.00e+00	0.00e+00	0.332	0.173	NK cells	pre
RAD21	ENSG00000164754	0.314229	0.00e+00	0.00e+00	0.49	0.313	NK cells	pre
ANXA6	ENSG00000197043	0.313609	0.00e+00	0.00e+00	0.74	0.601	NK cells	pre
AC016831.7	NA	0.313012	0.00e+00	0.00e+00	0.289	0.134	NK cells	pre
WDR1	ENSG00000071127	0.312687	0.00e+00	0.00e+00	0.628	0.461	NK cells	pre
NCOR1	ENSG00000141027	0.312133	0.00e+00	0.00e+00	0.548	0.383	NK cells	pre
SLC38A1	ENSG00000111371	0.311384	0.00e+00	0.00e+00	0.478	0.319	NK cells	pre

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56

In the post-treatment samples, the differentially expressed genes (|avg_log2FC|>0.25 & p_val_adj<0.05) between the resistant and sensitive groups for each cell type.

Gene symbol	Gene id	avg_log2FC	p_val	p_val_adj	pct.1	pct.2	Cell type	Timepoint
ACTB	ENSG00000075624	1.02077	5.27e-12	1.04e-07	1	0.955	Progenitors	post
ACTG1	ENSG00000184009	0.927729	9.42e-13	1.86e-08	1	0.951	Progenitors	post
NPM1	ENSG00000181163	0.869728	1.82e-14	3.60e-10	1	0.935	Progenitors	post
HLA-B	ENSG00000206450	0.84451	1.25e-12	2.46e-08	0.98	0.895	Progenitors	post
HNRNPA1	ENSG00000135486	0.829142	1.11e-11	2.19e-07	1	0.923	Progenitors	post
LAPTM4B	ENSG00000104341	0.822856	5.77e-10	1.14e-05	0.804	0.417	Progenitors	post
TUBA1B	ENSG00000123416	0.819877	1.74e-11	3.44e-07	0.843	0.393	Progenitors	post
EEF1A1	ENSG00000156508	0.793986	2.48e-12	4.89e-08	1	1	Progenitors	post
TUBB	ENSG00000235067	0.786445	7.89e-12	1.56e-07	0.922	0.583	Progenitors	post
H3F3B	NA	0.776868	5.98e-11	1.18e-06	0.98	0.737	Progenitors	post
RBM3	ENSG00000102317	0.773442	5.17e-11	1.02e-06	0.824	0.377	Progenitors	post
H2AFY	NA	0.772593	4.42e-12	8.73e-08	0.961	0.721	Progenitors	post
EEF1G	ENSG00000254772	0.762135	2.58e-12	5.09e-08	1	0.887	Progenitors	post
MT-ATP8	ENSG00000228253	0.757504	1.68e-08	3.31e-04	0.98	0.907	Progenitors	post
ZFP36L2	ENSG00000152518	0.752723	3.47e-09	6.85e-05	0.98	0.765	Progenitors	post
HSPA8	ENSG00000109971	0.684539	4.06e-08	8.01e-04	0.843	0.51	Progenitors	post
MT-ND4L	ENSG00000212907	0.683375	1.58e-08	3.12e-04	0.98	0.972	Progenitors	post
RPL3	ENSG00000100316	0.67673	4.31e-13	8.50e-09	1	1	Progenitors	post
HSP90AB1	ENSG00000096384	0.666922	6.93e-10	1.37e-05	0.98	0.903	Progenitors	post
RHOA	ENSG00000067560	0.663145	5.66e-10	1.12e-05	0.941	0.595	Progenitors	post
LDHB	ENSG00000111716	0.661659	2.23e-10	4.40e-06	1	0.85	Progenitors	post
NFE2	ENSG00000123405	0.657882	3.79e-09	7.48e-05	0.922	0.656	Progenitors	post
APEX1	ENSG00000100823	0.653985	2.84e-08	5.60e-04	0.863	0.615	Progenitors	post
PCBP1	ENSG00000169564	0.651123	2.45e-11	4.84e-07	0.824	0.372	Progenitors	post
SLC25A3	ENSG00000075415	0.64739	3.66e-10	7.22e-06	0.961	0.579	Progenitors	post
ATP5F1B	ENSG00000110955	0.642999	6.61e-10	1.31e-05	0.882	0.526	Progenitors	post
CITED2	ENSG00000164442	0.638512	2.48e-09	4.90e-05	0.569	0.182	Progenitors	post
ANP32B	ENSG00000136938	0.628867	3.04e-09	5.99e-05	0.941	0.761	Progenitors	post
EIF3L	ENSG00000100129	0.607148	2.76e-08	5.45e-04	1	0.717	Progenitors	post
PTMA	ENSG00000187514	0.604823	1.48e-11	2.91e-07	1	1	Progenitors	post
SET	ENSG00000119335	0.586183	2.56e-08	5.05e-04	0.882	0.583	Progenitors	post
SARAF	ENSG00000133872	0.584337	1.96e-08	3.88e-04	0.804	0.437	Progenitors	post
PAIP2	ENSG00000120727	0.580796	9.39e-09	1.85e-04	0.725	0.344	Progenitors	post
PEBP1	ENSG00000089220	0.56687	6.35e-09	1.25e-04	0.922	0.599	Progenitors	post
SRP9	ENSG00000143742	0.559114	1.83e-08	3.62e-04	0.686	0.291	Progenitors	post
PCBP2	ENSG00000197111	0.558041	6.98e-09	1.38e-04	1	0.874	Progenitors	post
ARHGDIB	ENSG00000111348	0.548551	5.55e-10	1.10e-05	1	0.903	Progenitors	post
CNBP	ENSG00000169714	0.544901	2.31e-08	4.57e-04	0.843	0.462	Progenitors	post
MORF4L1	ENSG00000185787	0.542778	3.02e-07	5.95e-03	0.765	0.441	Progenitors	post
NCL	ENSG00000115053	0.537875	2.42e-06	4.77e-02	0.804	0.502	Progenitors	post
NREP	ENSG00000134986	0.534974	5.04e-08	9.95e-04	0.765	0.381	Progenitors	post
H1FX	NA	0.532433	5.54e-07	1.09e-02	0.745	0.385	Progenitors	post
LDHA	ENSG00000288299	0.531597	2.65e-07	5.22e-03	0.765	0.441	Progenitors	post
IMPDH2	ENSG00000178035	0.529797	3.39e-07	6.69e-03	0.882	0.571	Progenitors	post
CD34	ENSG00000174059	0.52592	2.18e-06	4.30e-02	0.686	0.336	Progenitors	post
RAN	ENSG00000132341	0.521054	2.37e-06	4.68e-02	0.784	0.522	Progenitors	post
CALR	ENSG00000179218	0.516728	5.72e-08	1.13e-03	0.922	0.555	Progenitors	post
PGK1	ENSG00000102144	0.507758	1.93e-09	3.80e-05	0.725	0.291	Progenitors	post
RTRAF	ENSG00000087302	0.502776	6.30e-08	1.24e-03	0.843	0.547	Progenitors	post
SRSF9	ENSG00000111786	0.495059	1.75e-06	3.46e-02	0.725	0.437	Progenitors	post

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

This dataset only has one patient or is a cell line dataset, the resistant sample is the post-treatment sample and the sensitive sample is the pre-treatment sample. The following are differentially expressed genes (|avg_log2FC|>0.25 & p_val_adj<0.05) between the resistant and sensitive groups for each cell type.

Top

Mechanism analysis of drug resistance-related DEGs for each cell type in the pre-treatment samples

Enrichment results for 5 known drug-resistant mechanisms in malignant cells and 1 known mechanism in TME cells.The "Signature" column represents the differentially expressed genes (DEGs) used for enrichment. The "Geneset" column represents the genes included in this mechanism. The "Overlap" column represents the number of genes in the "Geneset" that are enriched in the "Signature". The "Enriched Genes" column represents the genes in the "Geneset" that are enriched in the "Signature". (If the image exists, the user can click on it to enlarge it in a new window.)

Enrichment results for 1 known drug resistance mechanisms in TME cells

Mechnism	Pval	FDR	Signature	Geneset	Overlap	Background	Cell type	Enriched Genes
Regulation by the Disease Microenvironment	3.70e-03	3.70e-03	384	186	9	23467	B cells	BCL2,CDKN1B,NFKB1,TGFBR2,ZEB2,PDCD6IP,HNRNPA2B1,VIM,MALAT1
Regulation by the Disease Microenvironment	4.00e-02	4.00e-02	399	186	7	23467	CD4+ T cells	BCL2,CDKN1B,NFKB1,TGFBR2,CXCR4,HNRNPA2B1,MALAT1
Regulation by the Disease Microenvironment	6.10e-01	6.10e-01	257	186	2	23467	CD8+ T cells	CDKN1B,CXCR4
Regulation by the Disease Microenvironment	2.90e-01	2.90e-01	454	186	5	23467	cDCs	NFKB1,TGFBR2,ZEB2,HNRNPA2B1,VIM
Regulation by the Disease Microenvironment	1.40e-01	1.40e-01	442	186	6	23467	Mono_Macro	TGFB1,TGFBR2,ZEB2,HNRNPA2B1,VIM,MALAT1
Regulation by the Disease Microenvironment	1.50e-01	1.50e-01	548	186	7	23467	NK cells	CDKN1B,TGFBR2,ZEB2,CX3CR1,PDCD6IP,HNRNPA2B1,STAT3
Regulation by the Disease Microenvironment	2.10e-01	2.10e-01	199	186	3	23467	pDCs	HNRNPA2B1,SMAD3,TSPYL2
Regulation by the Disease Microenvironment	5.30e-01	5.30e-01	94	186	1	23467	Plasma cells	CDKN1B

Hallmark, KEGG and GOBP enrichment results for up-regulated genes in resistant group of pre-treatment samples. Only show the top 50 pathways with fdr<0.05. If certain cell types are not displayed, it means that there are no significant pathways based on DEGs in those cell types. (If the image exists, the user can click on it to enlarge it in a new window. Complete files can be downloaded from the download section.)

Up-regulated Hallmark	Up-regulated KEGG	Up-regulated GO BP

Hallmark, KEGG and GOBP enrichment results for down-regulated genes in resistant group of pre-treatment samples. Only show the top 50 pathways with fdr<0.05. If certain cell types are not displayed, it means that there are no significant pathways based on DEGs in those cell types. (If the image exists, the user can click on it to enlarge it in a new window.Complete files can be downloaded from the download section.)

Down-regulated Hallmark	Down-regulated KEGG	Down-regulated GO BP

Top

Mechanism analysis of drug resistance-related DEGs for each cell type in the post-treatment samples

Enrichment results for 5 known drug resistance mechanisms in malignant cells and 1 known mechanism in TME cells.The "Signature" column represents the differentially expressed genes (DEGs) used for enrichment. The "Geneset" column represents the genes included in this mechanism. The "Overlap" column represents the number of genes in the "Geneset" that are enriched in the "Signature". The "Enriched Genes" column represents the genes in the "Geneset" that are enriched in the "Signature". (If the image exists, the user can click on it to enlarge it in a new window.)

Enrichment results for 1 known drug resistance mechanisms in TME cells

Mechnism	Pval	FDR	Signature	Geneset	Overlap	Background	Cell type	Enriched Genes
Regulation by the Disease Microenvironment	3.60e-01	3.60e-01	160	186	2	23467	B cells	HNRNPA2B1,MALAT1
Regulation by the Disease Microenvironment	2.30e-02	2.30e-02	77	186	3	23467	CD4+ T cells	VIM,LDHB,MALAT1
Regulation by the Disease Microenvironment	4.00e-02	4.00e-02	235	186	5	23467	CD8+ T cells	CXCR4,HNRNPA2B1,VIM,LDHB,MALAT1
Regulation by the Disease Microenvironment	5.20e-01	5.20e-01	348	186	3	23467	cDCs	TGFB1,VIM,MALAT1
Regulation by the Disease Microenvironment	5.50e-03	5.50e-03	89	186	4	23467	Mono_Macro	IL1B,RHOB,VIM,MALAT1
Regulation by the Disease Microenvironment	6.30e-01	6.30e-01	123	186	1	23467	NK cells	MALAT1
Regulation by the Disease Microenvironment	1.00e+00	1.00e+00	1	186	0	23467	pDCs	NA
Regulation by the Disease Microenvironment	3.90e-01	3.90e-01	169	186	2	23467	Plasma cells	RHOB,MALAT1
Regulation by the Disease Microenvironment	1.50e-01	1.50e-01	88	186	2	23467	Progenitors	LDHB,MALAT1

Hallmark, KEGG and GOBP enrichment results for up-regulated genes in resistant group of post-treatment samples. Only show the top 50 pathways with fdr<0.05. If certain cell types are not displayed, it means that there are no significant pathways based on DEGs in those cell types. (If the image exists, the user can click on it to enlarge it in a new window. Complete files can be downloaded from the download section.)

Up-regulated Hallmark	Up-regulated KEGG	Up-regulated GO BP

Hallmark, KEGG and GOBP enrichment results for down-regulated genes in resistant group of post-treatment samples. Only show the top 50 pathways with fdr<0.05. If certain cell types are not displayed, it means that there are no significant pathways based on DEGs in those cell types. (If the image exists, the user can click on it to enlarge it in a new window. Complete files can be downloaded from the download section.)

Down-regulated Hallmark	Down-regulated KEGG	Down-regulated GO BP

Top

Mechanism analysis of drug resistance-related DEGs for each cell type in one patient or cell lines

This dataset only has one patient or is a cell line dataset, the resistant sample is the post-treatment sample and the sensitive sample is the pre-treatment sample. Enrichment results for 5 known drug resistance mechanisms in malignant cells and 1 known mechanism in TME cells are shown here.The "Signature" column represents the differentially expressed genes (DEGs) used for enrichment. The "Geneset" column represents the genes included in this mechanism. The "Overlap" column represents the number of genes in the "Geneset" that are enriched in the "Signature". The "Enriched Genes" column represents the genes in the "Geneset" that are enriched in the "Signature". (If the image exists, the user can click on it to enlarge it in a new window.)

Hallmark, KEGG and GOBP enrichment results for up-regulated genes in resistant group. Only show the top 50 pathways with fdr<0.05. If certain cell types are not displayed, it means that there are no significant pathways based on DEGs in those cell types. (If the image exists, the user can click on it to enlarge it in a new window. Complete files can be downloaded from the download section.)

Hallmark, KEGG and GOBP enrichment results for down-regulated genes in resistant group. Only show the top 50 pathways with fdr<0.05. If certain cell types are not displayed, it means that there are no significant pathways based on DEGs in those cell types. (If the image exists, the user can click on it to enlarge it in a new window. Complete files can be downloaded from the download section.)

Top

MicroRNAs (miRNAs) regulating drug resistance-related DEGs for malignant cells

In the pre-treatment samples, the miRNAs with a score greater than 80 that regulate the top10 abs(avg_log2FC) drug resistance-related DEGs for malignant cells are shown here. If the gene does not have any miRNAs with a score greater than 80, it will not be shown. Here only the names of miRNAs with a score greater than 90 are shown, but some names will not be shown because of too many overlaps. (Complete files containing all datasets and cell types can be downloaded from the download section.)

Regulating up-regulated DEGs in resistant group	Regulating down-regulated DEGs in resistant group
This dataset does not contain malignant cells, nor does it predict any miRNA that corresponds to the top10 DEGs.	This dataset does not contain malignant cells, nor does it predict any miRNA that corresponds to the top10 DEGs.

In the post-treatment samples, the miRNAs with a score greater than 80 that regulate the top10 abs(avg_log2FC) drug resistance-related DEGs for Malignant cells are shown here. If the gene does not have any miRNAs with a score greater than 80, it will not be shown. Here only the names of miRNAs with a score greater than 90 are shown, but some names will not be shown because of too many overlaps. (Complete files containing all datasets and cell types can be downloaded from the download section.)

Regulating up-regulated DEGs in resistant group	Regulating down-regulated DEGs in resistant group
This dataset does not contain malignant cells, nor does it predict any miRNA that corresponds to the top10 DEGs.	This dataset does not contain malignant cells, nor does it predict any miRNA that corresponds to the top10 DEGs.

This dataset only has one patient or is a cell line dataset, the resistant sample is the post-treatment sample and the sensitive sample is the pre-treatment sample. The miRNAs with a score greater than 80 that regulate the top10 abs(avg_log2FC) drug resistance-related DEGs for Malignant cells are shown here. Here only the names of miRNAs with a score greater than 80 are shown, but some names will not be shown because of too many overlaps. If the gene does not have any miRNAs with a score greater than 90, it will not be shown. (Complete files containing all datasets and cell types can be downloaded from the download section.)

Top

Motifs and transcription factors (TFs) regulating drug resistance-related DEGs for each cell type

In the pre-treatment samples, the motifs and TFs that regulate drug resistance-related DEGs for each cell type are shown here. (Complete files can be downloaded from the download section.)

Motifs and TFs regulating up-regulated DEGs in resistant group of the pre-treatment samples

motif	motif	NES	AUC	TF_highConf	Cell_type
	hdpi__NRL	3.49	0.104	NRL (directAnnotation).	B cells
	flyfactorsurvey__Mad_FlyReg_FBgn0011648	3.41	0.103	SMAD9 (inferredBy_Orthology).	B cells
	cisbp__M00341	3.41	0.103	PAX6 (directAnnotation).	B cells
	cisbp__M00968	3.37	0.102	MTF2 (directAnnotation).	B cells
	metacluster_141.6	3.28	0.1	MZF1; TAF1; YY1; YY1; YY1; YY1; YY1; YY1; YY1; YY1; YY1; YY1; YY1; YY1; YY2; YY2; ZFP42; ZFP42; ZFP42; ZFP42; ZFP42; ZFP42; ZNF597 (directAnnotation). TAF1; TAF1L (inferredBy_Orthology).	B cells
	hdpi__FEZF2	3.27	0.1	FEZF2 (directAnnotation).	B cells
	hocomoco__TYY2_HUMAN.H11MO.0.D	3.26	0.0998	YY2 (directAnnotation).	B cells
	transfac_pro__M07310	3.23	0.0992	SP5 (directAnnotation).	B cells
	metacluster_67.2	3.19	0.0984	ZNF501 (directAnnotation). ACAA1; E2F2; E2F2; E2F3; E2F3; FOXN4 (inferredBy_Orthology).	B cells
	homer__TWVGGTCCGC_HINFP	3.18	0.0983	HINFP (directAnnotation).	B cells

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35

Motifs and TFs regulating down-regulated DEGs in resistant group of the pre-treatment samples

motif	motif	NES	AUC	TF_highConf	Cell_type
	transfac_pro__M06404	7.69	0.0949	ZNF497 (directAnnotation).	B cells
	swissregulon__hs__ETV6	6.21	0.0788	ETV6 (directAnnotation).	B cells
	metacluster_140.1	4.59	0.0612	BCL11B; BCL11B (directAnnotation).	B cells
	transfac_pro__M05711	4.57	0.061	ZNF37A (directAnnotation).	B cells
	taipale_tf_pairs__GCM1_ETV4_RTGCGGGCGGAAGTR_CAP	4.51	0.0603	ETV4; GCM1 (directAnnotation).	B cells
	cisbp__M02645	4.44	0.0596	ETS1 (directAnnotation).	B cells
	transfac_pro__M04923	4.42	0.0594	ZBTB33 (directAnnotation).	B cells
	taipale_tf_pairs__GCM2_PITX1_RTRCGGGSGATTAN_CAP_repr	4.37	0.0589	GCM2; PITX1 (directAnnotation).	B cells
	transfac_pro__M06322	4.36	0.0588	ZNF181 (directAnnotation).	B cells
	taipale_tf_pairs__ERF_HOXA3_RSCGGAWNNNNNNNYMATTA_CAP_repr	4.33	0.0584	ERF; HOXA3 (directAnnotation).	B cells

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53

In the post-treatment samples, the motifs and TFs that regulate drug resistance-related DEGs for each cell type are shown here. (Complete files can be downloaded from the download section.)

Motifs and TFs regulating up-regulated DEGs in resistant group of the post-treatment samples

motif	motif	NES	AUC	TF_highConf	Cell_type
	metacluster_141.4	7.77	0.136	GLIS2 (directAnnotation).	B cells
	hocomoco__TYY2_HUMAN.H11MO.0.D	6.74	0.122	YY2 (directAnnotation).	B cells
	taipale__YY2_DBD_NNCCGCCATNW_repr	5.87	0.109	YY2 (directAnnotation).	B cells
	transfac_pro__M06259	5.06	0.0982	ZNF91 (directAnnotation).	B cells
	metacluster_141.2	5.05	0.0979	E2F2; E2F3 (directAnnotation).	B cells
	tfdimers__MD00351	4.69	0.093	IRF8; RFX1; RFX2; RFX3; RFX4; RFX5; RFXANK; RFXAP (directAnnotation).	B cells
	flyfactorsurvey__pho_SOLEXA_F1-3	4.63	0.0921	YY1 (inferredBy_Orthology).	B cells
	metacluster_2.8	4.27	0.0872	IRF4; IRF5; IRF6; IRF9 (directAnnotation). IRF3; IRF5; IRF5; IRF6 (inferredBy_Orthology).	B cells
	transfac_pro__M06715	3.64	0.0784	ZNF331 (directAnnotation).	B cells
	stark__RCGCMATTW	3.63	0.0783	YY1 (inferredBy_Orthology).	B cells

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36

Motifs and TFs regulating down-regulated DEGs in resistant group of the post-treatment samples

motif	motif	NES	AUC	TF_highConf	Cell_type
	swissregulon__hs__ETV6	7.27	0.123	ETV6 (directAnnotation).	B cells
	hdpi__FLI1	7.2	0.122	FLI1 (directAnnotation).	B cells
	metacluster_2.7	6.53	0.111	IRF1; IRF1; IRF2; IRF2; IRF3; IRF4; IRF5; IRF6; IRF7; IRF7; IRF8; IRF8; IRF9; PRDM1; PRDM1; PRDM1; PRDM1; PRDM1; PRDM1; PRDM1; PRDM1; PRDM1; PRDM1; PRDM1; PRDM1; STAT1; STAT1; STAT2 (directAnnotation). PRDM1; PRDM1; PRDM1 (inferredBy_Orthology).	B cells
	metacluster_2.6	5.92	0.102	IRF1; IRF1; IRF1; IRF1; IRF1; IRF1; IRF1; IRF1; IRF1; IRF1; IRF2; IRF2; IRF2; IRF2; IRF2; IRF2; IRF2; IRF3; IRF3; IRF3; IRF3; IRF3; IRF3; IRF4; IRF4; IRF4; IRF4; IRF4; IRF5; IRF5; IRF5; IRF5; IRF5; IRF5; IRF5; IRF6; IRF7; IRF7; IRF7; IRF7; IRF7; IRF7; IRF7; IRF8; IRF8; IRF8; IRF8; IRF8; IRF8; IRF8; IRF8; IRF9; IRF9; IRF9; IRF9; IRF9; IRF9; IRF9; STAT1; STAT2; STAT2; STAT2; STAT2; ZNF426; ZNF71 (directAnnotation). IRF1; IRF1; IRF3; IRF8 (inferredBy_Orthology).	B cells
	transfac_pro__M06763	5.43	0.0949	ZNF225 (directAnnotation).	B cells
	transfac_pro__M04887	5.16	0.091	TCF12 (directAnnotation).	B cells
	metacluster_2.8	5	0.0885	IRF4; IRF5; IRF6; IRF9 (directAnnotation). IRF3; IRF5; IRF5; IRF6 (inferredBy_Orthology).	B cells
	metacluster_79.12	4.82	0.0859	ZNF257 (directAnnotation).	B cells
	jaspar__MA1509.1	4.75	0.0847	IRF6 (directAnnotation).	B cells
	metacluster_161.15	4.73	0.0845	NKX3-1 (directAnnotation).	B cells

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56

This dataset only has one patient or is a cell line dataset, the resistant sample is the post-treatment sample and the sensitive sample is the pre-treatment sample. Motifs and TFs that regulate drug resistance-related DEGs for each cell type are shown here. (Complete files can be downloaded from the download section.)

Top

Differentially expressed genes act as transcription factors

This table shows the differentially expressed genes that act as transcription factors. (Complete files can be downloaded from the download section.)

TF	motif	Expression	Cell type	Timepoint
JUNB	metacluster_137.2	up	CD8+ T cells	post
CEBPD	taipale_tf_pairs__ETV2_CEBPD_RSCGGANNTTGCGYAAN_CAP_repr	up	cDCs	post
SPI1	metacluster_167.5	up	cDCs	post
FOS	tfdimers__MD00165	down	Mono/Macro	post
FOSB	tfdimers__MD00165	down	Mono/Macro	post
JUN	tfdimers__MD00165	down	Mono/Macro	post
JUNB	tfdimers__MD00165	down	Mono/Macro	post
JUND	tfdimers__MD00165	down	Mono/Macro	post
CEBPB	taipale_tf_pairs__GCM1_CEBPB_ATRSGGGNNNNTTRCGYAAN_CAP_repr	down	Mono/Macro	post
CEBPB	tfdimers__MD00359	down	Mono/Macro	post

Page: 1 2

1	"Sun X, Zhang Y, Li H, Zhou Y, Shi S, Chen Z, He X, Zhang H, Li F, Yin J, Mou M, Wang Y, Qiu Y, Zhu F. DRESIS: the first comprehensive landscape of drug resistance information. Nucleic Acids Res. 2023 Jan 6;51(D1):D1263-D1275. doi: 10.1093/nar/gkac812. PMID: 36243960; PMCID: PMC9825618."
2	"Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, Assempour N, Iynkkaran I, Liu Y, Maciejewski A, Gale N, Wilson A, Chin L, Cummings R, Le D, Pon A, Knox C, Wilson M. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082. doi: 10.1093/nar/gkx1037. PMID: 29126136; PMCID: PMC5753335."